---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-006880"
form_type: "8-K"
ticker: "XTNT"
cik: "0001453593"
company_name: "Xtant Medical Holdings, Inc."
filed_at: "2023-03-07T23:59:59+00:00"
generated_at: "2026-06-18T09:36:54.159556+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Xtant Medical Q4 revenue up 9% to $15.3M; full year net loss widens to $8.5M

## Summary
- Q4 revenue $15.3M, up 9% YoY; full year revenue $58.0M, up 5% YoY.
- Q4 net loss $2.2M ($0.02 per share), vs $2.3M ($0.03) in prior year.
- Full year net loss $8.5M ($0.09 per share), up from $4.8M ($0.06) in 2021.
- Non-GAAP Adjusted EBITDA full year loss $3.0M vs gain $0.3M in 2021.
- Acquired Coflex product line to enhance fixation offering; financial details not disclosed.

## SEC filing metadata
- accession: 0001493152-23-006880
- form_type: 8-K
- ticker: XTNT
- cik: 0001453593
- company_name: Xtant Medical Holdings, Inc.
- filed_at: 2023-03-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1453593/000149315223006880/0001493152-23-006880-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1453593/000149315223006880/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-006880
- JSON: https://secwatch.observer/filing/0001493152-23-006880.json
- Plain text: https://secwatch.observer/filing/0001493152-23-006880.txt

## Key facts
- Earnings Releases
  Xtant Medical Holdings, Inc. reported the fourth quarter and year ended December 31, 2022 results: revenue $15.3 million, net income $0.02 per share, EPS $0.02 per share.
  - Period: the fourth quarter and year ended December 31, 2022
  - Revenue: $15.3 million
  - Net income: $0.02 per share
  - EPS: $0.02 per share
  - Result: reported results
  source text: network, all of which are core focus areas to our long-term growth strategy.” Fourth Quarter and Full Year 2022 Financial Results Fourth quarter 2022 revenue grew 9% to $15.3 million, compared to $14.0 million for the same quarter in 2021. Full year 2022 revenue was $58.0 million, compared to $55.3 million for 2021. The increase in revenue was largely
  evidence_url: https://www.sec.gov/Archives/edgar/data/1453593/000149315223006880/0001493152-23-006880-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.